A study of inCVAX for the prevention of breast cancer.

Trial Profile

A study of inCVAX for the prevention of breast cancer.

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 18 Sep 2016

At a glance

  • Drugs N-dihydro-galacto-chitosan (Primary)
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Sep 2016 According to an Immunophotonics media release, first patient is dosed in this study
    • 18 Sep 2016 New trial record
    • 23 Aug 2016 According to an Immunophotonics media release, the company plans for an US Investigational New Drug submission in 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top